An interventional study of Eatable Alphabet and Usual Care in Child Overnutrition, Child Obesity and Child Nutrition Disorders, sponsored by Northwell Health. Active, not recruiting at 1 site in United States. Open to participants aged 2 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by Northwell Health · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Child Nutrition Disorders with a site in United States — 3 open to participants now, 4 under way, none of them phase 3. Child Nutrition Disorders · United States.
Among the 15 studies in Child Nutrition Disorders with a site in United States, this one is the 6th largest by planned enrollment of the 14 interventional ones that give a count, is one of 4 that started in 2023, is one of 10 with no phase, and was the 7th registered.
168 studies on the registry are indexed under Child Nutrition Disorders; 34 are open to participants now.
Browse Child Nutrition Disorders studies →3 of the 15 studies in Child Nutrition Disorders with a site in United States are open now. Recruiting first, the newest first:
Boston Children's Hospital · Sites in United States
Ages 2–18
Fresenius Kabi · Sites in United States
Ages 1 mo–17 yrs
Drexel University · Sites in United States
Ages 5–21
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 23 Child Nutrition Disorders studies recruiting now, 3 (13%) set no upper age limit and 20 (87%) stop at 75 or younger; 19 take children under 18; 13 take healthy volunteers.
This study: 2 Years to 10 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 4 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 160 is below the median of 400 across 133 interventional studies indexed under Child Nutrition Disorders.
Median enrollment 120 across the 14 interventional studies, 0 across the 1 observational. Of the 10 that completed or were terminated, 3 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 15 have an industry lead sponsor. The 10 most frequent:
Northwell Health is the lead sponsor of 476 studies on the registry; 106 are open to participants now.
Of its 48 completed or terminated interventional studies of FDA-regulated products, 23 (48%) have results posted.
Northwell Health has 1 study filed under Child Nutrition Disorders — fewer than ten, so there is no comparison to draw.
3 of the studies in Child Nutrition Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06049680Fresenius KabiSafety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients | 2026-11 |
| NCT05166629Northwell HealthEatable Alphabet as a Nutrition Education Tool | 2026-12-31 |
| NCT06356220Boston Children's HospitalGF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health) | 2027-05 |
Add all 3 to your calendar (.ics) → With an account.
Among the 15 studies in Child Nutrition Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This pilot randomized controlled trial will test the effectiveness of Eatable Alphabet cards, a child friendly nutrition education tool, on child weight and related behaviors in a clinical sample of 2 to 10-year-old children with overweight/obesity, referred to a pediatric weight management program.
The goal of this research study is to determine whether the use of Eatable Alphabet cards in addition to standard weight management in a primary care setting will increase vegetable consumption. Additional outcomes that will be examined include fruit consumption, child engagement in meal selection and preparation, and clinic follow-up. If the intervention shows a significant effect in the above outcome measures, Eatable Alphabet cards can be implemented as a standard component of obesity management in primary care settings. It is hypothesized that the intervention will increase vegetable consumption, increase child engagement in meal selection and preparation, and increase clinic follow-up.
The study design is randomized control trial, in which the control group includes parent-child dyads receiving care as usual in the weight management program, including nutrition education, and the intervention group includes parent-child dyads receiving care as usual in the weight management program plus Eatable Alphabet cards in addition to typical nutrition education. All study participants will be families receiving care at the POWER Kids Weight Management Program at 410 Lakeville Road, with the child between the ages of 2 and 10 who have overweight or obesity. The primary outcome is parent reported frequency of child vegetable consumption. Secondary outcomes include: parent reported frequency of child fruit consumption, parent reported child engagement in meal selection/preparation, follow-up weight management visit attendance, and child anthropometric outcomes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
- No appropriate caregiver available for consent.
Usual care in the POWER Kids weight management program includes a nutrition assessment and education by a registered dietician nutritionist (RD). This includes taking a detailed dietary history, and providing individualized counseling, motivational interviewing, and nutrition education handouts/ web-based resources.
Behavioral: Usual Care
The intervention group will receive usual care, as described above, plus a set of Eatable Alphabet cards, which will be utilized during the visit for counseling and education, and given to the family to take home and use as they wish.
Behavioral: Eatable Alphabet
Eatable Alphabet is a set of kitchen activity cards developed by ChopChop Family, in collaboration with the American Academy of Pediatrics, with funding from the CDC (https://www.chopchopfamily.org/eatable-alphabet/). It includes a series of alphabet cards with family-friendly recipes.
Please see above description of usual care.
Change in parent reported child vegetable consumption (servings/day)
Parents will complete pre and post intervention/usual care survey measures of vegetable consumption.
Time frame: 1 month
Change in parent reported child fruit consumption (servings/day)
Parents will complete pre and post intervention/usual care survey measures of fruit consumption.
Time frame: 1 month
Parent reported child engagement in meal selection/preparation
Parents will complete pre and post intervention/usual care survey measures of child engagement in meal selection/preparation.
Time frame: 1 month
Follow-up weight management visit attendance
We will determine whether the patient returned for scheduled follow-up visit via medical record review.
Time frame: 6 months
Change in child body mass index (BMI) z-score
Weight and height measured by clinical staff at the baseline visit and all subsequent visits over the next six months will be used to calculate body mass index (BMI=kg/m\^2). Software will use Centers for Disease Control and Prevention (CDC) reference standards to convert BMI into a BMI z-score based on the child's age and sex. Change in BMI z-score will be defined as BMI z-score 6 months (+/- 3 months) after the intervention visit minus BMI z-score at the baseline intervention visit.
Time frame: 6 months
Change in weight for age (WFA) z-score
Weight measured by clinical staff at the baseline visit and all subsequent visits over the next six months will be used to generate weight for age (WFA) z-scores using CDC reference standards. Change in WFA z-score will be defined as WFA z-score 6 months (+/- 3 months) after the intervention visit minus WFA z-score at the baseline intervention visit.
Time frame: 6 months
Change in percent of the 95th percentile of BMI for age and sex
Weight and height measured by clinical staff at the baseline visit and all subsequent visits over the next six months will be used to calculate body mass index (BMI=kg/m\^2). Software will use CDC reference standards to convert BMI into a percent of the 95th percentile for the child's age and sex. Change in percent of the 95th percentile will be defined as percent of the 95th percentile 6 months (+/- 3 months) after the intervention visit minus percent of the 95th percentile z-score at the baseline intervention visit.
Time frame: 6 months
Plan to share: No
Started Sep 2023 (actual). Primary completion is estimated for Dec 2026, 39 months after the start.
Of 83 non-industry interventional studies with no phase under Child Nutrition Disorders, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's planned 39 months is above that.
Counting every sponsor, half of 86 studies reached it within 18 months; a quarter within 9 and three quarters within 35.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: primary completion Sep 2026 → Dec 2026 and completion Dec 2026 → Mar 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.